BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $5.00 million. The enterprise value is $1.39 million.
Important Dates
The last earnings date was Friday, May 15, 2026, after market close.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BGLC has 2.42 million shares outstanding. The number of shares has increased by 12.43% in one year.
| Current Share Class | 2.42M |
| Shares Outstanding | 2.42M |
| Shares Change (YoY) | +12.43% |
| Shares Change (QoQ) | +18.67% |
| Owned by Insiders (%) | 27.46% |
| Owned by Institutions (%) | 0.11% |
| Float | 1.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.94 |
| Forward PS | n/a |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.52 |
| Quick Ratio | 5.27 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -173.57 |
Financial Efficiency
Return on equity (ROE) is -36.62% and return on invested capital (ROIC) is -66.31%.
| Return on Equity (ROE) | -36.62% |
| Return on Assets (ROA) | -20.76% |
| Return on Invested Capital (ROIC) | -66.31% |
| Return on Capital Employed (ROCE) | -37.31% |
| Weighted Average Cost of Capital (WACC) | 15.48% |
| Revenue Per Employee | $279,509 |
| Profits Per Employee | -$152,887 |
| Employee Count | 19 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.59% in the last 52 weeks. The beta is 2.19, so BGLC's price volatility has been higher than the market average.
| Beta (5Y) | 2.19 |
| 52-Week Price Change | -29.59% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 3.78 |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 6,335 |
Short Selling Information
The latest short interest is 9,982, so 0.41% of the outstanding shares have been sold short.
| Short Interest | 9,982 |
| Short Previous Month | 9,968 |
| Short % of Shares Out | 0.41% |
| Short % of Float | 0.57% |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, BGLC had revenue of $5.31 million and -$2.90 million in losses. Loss per share was -$1.44.
| Revenue | 5.31M |
| Gross Profit | 740,934 |
| Operating Income | -3.08M |
| Pretax Income | -2.90M |
| Net Income | -2.90M |
| EBITDA | -2.96M |
| EBIT | -3.08M |
| Loss Per Share | -$1.44 |
Full Income Statement Balance Sheet
The company has $3.96 million in cash and $346,624 in debt, with a net cash position of $3.62 million or $1.50 per share.
| Cash & Cash Equivalents | 3.96M |
| Total Debt | 346,624 |
| Net Cash | 3.62M |
| Net Cash Per Share | $1.50 |
| Equity (Book Value) | 8.09M |
| Book Value Per Share | 3.35 |
| Working Capital | 4.40M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$1.16 million and capital expenditures -$28,244, giving a free cash flow of -$1.19 million.
| Operating Cash Flow | -1.16M |
| Capital Expenditures | -28,244 |
| Depreciation & Amortization | 113,524 |
| Net Borrowing | 92,874 |
| Free Cash Flow | -1.19M |
| FCF Per Share | -$0.49 |
Full Cash Flow Statement Margins
Gross margin is 13.95%, with operating and profit margins of -57.91% and -54.70%.
| Gross Margin | 13.95% |
| Operating Margin | -57.91% |
| Pretax Margin | -54.70% |
| Profit Margin | -54.70% |
| EBITDA Margin | -55.77% |
| EBIT Margin | -57.91% |
| FCF Margin | n/a |
Dividends & Yields
BGLC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.43% |
| Shareholder Yield | -12.43% |
| Earnings Yield | -58.05% |
| FCF Yield | -23.79% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 7, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
BGLC has an Altman Z-Score of 3.89 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.89 |
| Piotroski F-Score | 3 |